Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/2/2020
SIETES contiene 92914 citas

 
 
<< anterior 21 a 40 de 145 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Hulot J-S, Collet J-P, Montalescot G. Genetic substudy of the PLATO trial. Lancet 2011;377:637. [Ref.ID 90238]
22.Tiene citas relacionadas Cita con resumen
Bhatt DL, Laine L, Cannon CP. Clopidogrel with or without omeprazole in coronary disease. The authors reply. N Engl J Med 2011;364:682. [Ref.ID 90219]
23.Tiene citas relacionadas Cita con resumen
Juurlink DN. Clopidogrel with or without omeprazole in coronary disease. N Engl J Med 2011;364:681-2. [Ref.ID 90218]
24.Tiene citas relacionadas Cita con resumen
Sadek A, Ford AC. Clopidogrel with or without omeprazole in coronary disease. N Engl J Med 2011;364:681. [Ref.ID 90217]
25.Tiene citas relacionadas Cita con resumen
Wallentin L, James S, Storey RF, Armstrong M, Barratt BJ, Horrow J, Husted S, Katus H, Steg PG, Shah SH, for the PLATO Investigators. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Lancet 2010;376:1320-8. [Ref.ID 89890]
26.Tiene citas relacionadas Cita con resumen
Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP, for the COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010;363:1909-17. [Ref.ID 89643]
27. Cita con resumen
Paré G, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Hirsh J, Simonsen K, Bhatt DL, Fox KAA, Eikelboom JW. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med 2010;363:1704-14. [Ref.ID 89554]
28.Enlace a cita original
Futura T, Iwaki T, Umemura K. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel n relation to CYP2C19 genotypes. Br J Clin Pharmacol 2010;70:383-92. [Ref.ID 89322]
29.Enlace a cita original
Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Shceiman J, Sperling LS, Tomaselli GF, American College of Cardiology Foundation Task Force on Expert Consensus Documents. ACCF/ACCG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 Expert Consensus Document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. J Am Coll Cardiol 2010;56:2051-66. [Ref.ID 89235]
30.Tiene citas relacionadas Cita con resumen
Mega JL, Simon T, Collet J-P, Anderson JL, Antman EM, Bliden K, Cannon CP, Danchin N, Giusti B, Gurbel P, Horne BD, Hulot JS, Kastrati A, Montalescot G, Neumann F-J, Shen L, Sibbing D, Steg PG, Trenk D, Wiviott SD, Sabatine MS. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI. A meta-analysis. JAMA 2010;304:1821-30. [Ref.ID 89227]
31.Tiene citas relacionadas Cita con resumen
Fuster V, Sweeny JM. Clopidogrel and the reduced-function CYP2C19 genetic variant. JAMA 2010;304:1839-8140. [Ref.ID 89226]
32. Cita con resumen
Anónimo. Armodafinil (Nuvigil) for wakefulness. Med Lett Drugs Ther 2010;52:61-2. [Ref.ID 89080]
33. Cita con resumen
Anónimo. Poor metabolizers of clopidogrel (Plavix). Med Lett Drugs Ther 2010;52:33. [Ref.ID 88490]
34.Enlace a cita original
Helsby NA, Lo W-Y, Simpson IJ, Voss DM, Logan KE, Searle M, Schollum JBW, de Zoysa JR. Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype. Br J Clin Pharmacol 2010;69:516-9. [Ref.ID 88441]
36. Cita con resumen
Juurlink DN. Proton pump inhibitors and clopidogrel: Putting the interaction in perspective. Circulation 2009;120:2310-2. [Ref.ID 87817]
38.Enlace a cita original Cita con resumen
Anónimo. Clopidogrel interaction. JAMA 2010;303:322. [Ref.ID 87726]
39.Tiene citas relacionadas Cita con resumen
O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Wiviott SD. Combination therapy with clopidogrel and proton-pump inhibitors. Authors' reply. Lancet 2010;375:28-9. [Ref.ID 87529]
40.Tiene citas relacionadas Cita con resumen
Bhala N, Banerjee A. Combination therapy with clopidogrel and proton-pump inhibitors. Lancet 2010;375:28. [Ref.ID 87528]
Seleccionar todas
 
<< anterior 21 a 40 de 145 siguiente >>